Navigation Links
Anacor Raises $50 Million in Equity Financing
Date:1/6/2009

PALO ALTO, Calif., Jan. 6 /PRNewswire/ -- Anacor Pharmaceuticals today announced that it has raised $50 million through a preferred stock financing with participation from GlaxoSmithKline, Schering Corporation and existing investors including Rho Capital Partners, Venrock Associates, Care Capital and Aberdare Ventures. Proceeds from the financing will be used to further develop Anacor's product pipeline based on its boron chemistry platform.

"We are pleased to complete this financing, which will allow us to advance our five clinical programs and to identify and progress new compounds derived from our boron chemistry platform," said David Perry, Chief Executive Officer at Anacor Pharmaceuticals.

The investments from GSK and Schering Corporation fulfill each company's investment obligations pursuant to their respective and ongoing collaborations with Anacor. At the conclusion of the financing, the combined ownership of GSK and Schering Corporation will be less than 20 percent of Anacor's outstanding shares.

About Anacor Pharmaceuticals

Anacor is a biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform. Anacor has focused initially on developing topical applications of its compounds to treat fungal, bacterial and inflammatory diseases. Anacor's most advanced product candidate is AN2690, a novel topical antifungal in development for the treatment of toenail onychomycosis, which is a fungal infection of the nail and nail bed. AN2690 is licensed to Schering under a worldwide development and commercialization agreement for all indications including the treatment of onychomycosis. Anacor also has a research and development collaboration with GlaxoSmithKline for the discovery, development, manufacture and worldwide commercialization of novel systemic therapeutics for viral and bacterial diseases utilizing Anacor's boron-based
'/>"/>

SOURCE Anacor Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
2. Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
3. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
4. Anacor Files Registration Statement for Initial Public Offering
5. MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile
6. Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture
7. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
8. Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
9. Ameristar National Charity Golf Classic Raises More Than $1.1 Million for Buoniconti Fund to Cure Paralysis and Christopher & Dana Reeve Foundation
10. China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income
11. MacroGenics Raises $25M in Series D-2 Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...TOCKHOLM, November 20 Karolinska D...vestment Fund (EIF) has entered into a,co-investme...und will be,managed by Karolinska Development and ...-stage pharmaceutical and medical technology compa... co-investment fund. The agreement,represents EIF,...
(Date:11/19/2009)..., Nov. 19 Danish Prince Joachim in...thanol plant in Kalundborg, Denmark, on Wednesday,...irst and largest 2nd generation ethanol demonstrat...are used in the plant,s innovative process for con...isco, was the first to market with commercial enzy...
(Date:11/19/2009)... Md., Nov. 19 Spherix In...chnology for diabetes therapy, and a provider of t...d, supplement, biotechnology and pharmaceutical co...Annual Meeting of Shareholders. ,, At the meeti... SPEX ) elected the following members to the Board...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies Form In...ordinate Best Practices in Risk Reduction ,Five ... Gene Synthesis Capacity , ...squo;s leading gene synthesis companies today anno...ening protocol to promote biosecurity in the gene ...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...t time in the team,s history, the University of W...d first in the nation, giving Wisconsin fans just ... around the corner, and I know the team will enjoy...,But our support for the entire University of Wis...A tournament. The UW system is a vital institution...
... the technology associated with his digital produc...o address its flaws and transform it for the voice...y-stage Madison business called VoVison , has amb...n technology, which has three differentiating feat...the ability to work with multiple voices. , ,The t...
...e had the chance to play a bit more with the indep...d at the conference, Jaman.com offers a growing li... that average about $6 per film. , ,While you can ...n.com experience is the downloadable player, a des...rpose-built browser . The player manages download...
Other Biology Technology:Fueling our economy with the University of Wisconsin 2Fueling our economy with the University of Wisconsin 3Fueling our economy with the University of Wisconsin 4Tech upstart VoVision could disrupt the voice-recognition market 2Tech upstart VoVision could disrupt the voice-recognition market 3Tech upstart VoVision could disrupt the voice-recognition market 4We're "Jaman": Purpose-driven browsers drive next wave of Web applications 2We're "Jaman": Purpose-driven browsers drive next wave of Web applications 3
(Date:11/19/2009)...ire-FirstCall/ -- BIO-key International, Inc. (OTC...c safety and finger-based biometric identification... Meeting held today was adjourned without any acti..., (Logo: http://www.newscom.com/cgi-bin/prnh/2...% of the 35 million votes cast voted in favor of t...
(Date:11/19/2009)... T. Ming Chu Professor of Biochemistry and Molecul...ng how regulatory proteins control the production ...rking with collaborators including Drs. Mitchell W...ladelphia, they focused specifically on the comple...es). These cells contain large amounts of hemoglob...
(Date:11/19/2009)...professor of paleontology in the McMicken College ... the University of Chicago publish their research ..., "Epicontinental Seas Versus Open-Ocean Settings:... , For many years, paleobiological researchers i...sed on charting the many ups (evolutionary radiati...
Breaking Biology News(10 mins):BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Where surgery was the standard casting may be the future 58548 1Where surgery was the standard casting may be the future 58548 2Amid rising concerns 600 global biodiversity experts meet in Cape Town Oct 13 16 10185 1Study Finds Fish Wont Prevent Heart Failure 58544 1Study Finds Fish Wont Prevent Heart Failure 58544 2Study Finds Fish Wont Prevent Heart Failure 58544 3
...n genes on and off now looks to be more like a cel...ancer Institute at the University of Utah, report ... , The scientists showed for the first time that ...ied ?flexible, randomly structured regions believe...hey become important in turning genes on and off, ...
... Medical School have discovered the biological equ... of primitive, blood-forming stem cells in mice. C...all the different types of specialized cells found...an separate stem cells from their more advanced de...tted to becoming one type of blood cell. The secre...
...apies were introduced for neglected diseases, whic...of the equivalent of 92m years, of healthy life, t...ay. , In the PLoS Medicine analysis, which is base...Trust, Mary Moran of the London School of Economic...ts are conducted under the umbrella of drug develo...
Other Biology News:A 'dimmer switch' for genes 2A 'dimmer switch' for genes 3U-M scientists discover identifying markers for primitive blood-forming stem cells 2U-M scientists discover identifying markers for primitive blood-forming stem cells 3U-M scientists discover identifying markers for primitive blood-forming stem cells 4
...us venom Description: Phosphodiesterase I (venom e...d structure and sequence (1) . It hydrolyzes 5'-mo...onucleotides and deoxyribo-oligonucleotides (2) . ...ns at the pyrophosphate linkages to yield phosphor...
Spacer for Miniature FRENCH Pressure Cell from Thermo Scientific
...criptase is a recombinant Moloney murine leukemia ... Reverse Transcriptase is similar to MuLV reverse .... MuLV reverse transcriptase is a recombinant RNA-... RNA as a template in the presence of a primer to ...
...to Prostaglandin F2α (8-iso-13,14-dihydro-1...stane, 8-isoprostane (8-iso PGF2α), in rabb...G-like product of non-specific lipid peroxidation....-isoprostane is converted primarily to metabolites...
Biology Products: